In those that did resolve, the existing study reported a PsP duration of 6 months, similar to the 8-month interval reported here.6 Overall our results expand upon the previous study of PsP in IDH mutant gliomas by including low-grade patients and reveals that PsP has similar characteristics in low and high-grade IDH mutant gliomas. The gene discussed is IDH1; the disease is glioma.